Replimune Group Inc.

NASDAQ: REPL
Share price (12/20/24): $12.49
Market cap (12/20/24): $855 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q2

ended 06/30/24 Q1

ended 03/31/24 FY 2024

ended 12/31/23 Q3

ended 09/30/23 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Xynos Konstantinos

Sarchi Christopher

Omega Fund IV, L.P.

News Filter

Other Events, Financial Statements or Exhibits

Announces Proposed Public Offering

Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA Under the Accelerated Approval Pathway

Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Scanned paper annual report submission